Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma
Clinical trial NCT03057795 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03057795
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-03
- Primary completion
- 2021-01-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.